T(SCM)-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trial
以T(SCM)为主的异基因抗BCMA CAR-T疗法治疗复发/难治性多发性骨髓瘤:临床前特征及1期临床试验中期结果
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-65267-0
Tseng, Hubert; Dholaria, Bhagirathbhai; Cranert, Stacey A; Richter, Maximilian; Marquez, Karl S; Cho, Benjamin S; Bacong, Andrew; McArthur, Katherine; Eskew, Jeff D; McCaigue, Joanne; Haag, Sabrina; Krasny, Aly; Solimine, Brian; Coffey, Michael J; Loyola, Aimee; Kwong, Jasmine; Shune, Leyla; Kin, Andrew; Costello, Caitlin L; Kocoglu, Mehmet H; Ramakrishnan, Aravind; Namini, Hamid; Martin, Christopher E; Belani, Rajesh; Coronella, Julia; Shedlock, Devon J